WARRANTWarrant Agreement • March 11th, 2004 • Cytokinetics Inc • Pharmaceutical preparations
Exhibit 4.5 LOAN AND SECURITY AGREEMENT THIS AGREEMENT (the "Agreement"), dated as of December 16, 1999 (the "Closing Date") is entered into by and between Cytokinetics, Incorporated, a Delaware corporation having a principal place of business at 280...Loan and Security Agreement • January 27th, 2004 • Cytokinetics Inc • Illinois
RECITALSAssignment and Assumption Agreement • January 27th, 2004 • Cytokinetics Inc • California
Exhibit 1.1 CYTOKINETICS, INCORPORATED COMMON STOCK, $0.001 PAR VALUE UNDERWRITING AGREEMENTUnderwriting Agreement • March 11th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • New York
CYTOKINETICS, INCORPORATED AND _____________, AS TRUSTEE FORM OF INDENTURE DATED AS OF __________ Debt SecuritiesIndenture • November 18th, 2022 • Cytokinetics Inc • Pharmaceutical preparations • New York
THIS INDENTURE, dated as of [•], between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
Exhibit 10.6 FIRST AMENDMENT TO LEASE THIS FIRST AMENDMENT TO LEASE ("Amendment"), dated (for reference purposes) as of April 13, 1998, is entered into by BRITANNIA POINTE GRAND LIMITED PARTNERSHIP, a Delaware limited partnership ("Landlord") and...Lease • January 27th, 2004 • Cytokinetics Inc
Cytokinetics, Incorporated Shares of Common Stock (par value $0.001 per share) Amended and Restated Controlled Equity OfferingSM Sales AgreementSales Agreement • March 1st, 2023 • Cytokinetics Inc • Pharmaceutical preparations
Cytokinetics, Incorporated, a Delaware corporation (the “Company”), confirms its amended and restated agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
RECITALSModification Agreement • January 27th, 2004 • Cytokinetics Inc
RECITALSInvestors' Rights Agreement • January 27th, 2004 • Cytokinetics Inc • California
RECITALSExecutive Employment Agreement • November 12th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • California
CYTOKINETICS, INCORPORATED AND _____________, AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF __________ CYTOKINETICS, INCORPORATED FORM OF PREFERRED STOCK WARRANT AGREEMENTPreferred Stock Warrant Agreement • November 18th, 2022 • Cytokinetics Inc • Pharmaceutical preparations • New York
THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
Exhibit 4.3 LOAN AND SECURITY AGREEMENT THIS AGREEMENT (the "Agreement"), dated as of September 25, 1998 (the "Closing Date") is entered into by and between Cytokinetics, Incorporated, a Delaware corporation having a principal place of business at 280...Loan and Security Agreement • January 27th, 2004 • Cytokinetics Inc • Illinois
CYTOKINETICS, INCORPORATED AND , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OFCommon Stock Warrant Agreement • November 6th, 2019 • Cytokinetics Inc • Pharmaceutical preparations • New York
THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
CYTOKINETICS, INCORPORATED AND _____________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF __________ CYTOKINETICS, INCORPORATED FORM OF DEBT SECURITIES WARRANT AGREEMENTWarrant Agreement • November 18th, 2022 • Cytokinetics Inc • Pharmaceutical preparations • New York
THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [•], between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
BACKGROUNDCollaboration Agreement • January 27th, 2004 • Cytokinetics Inc • California
5,260,000 Shares of Common Stock CYTOKINETICS, INCORPORATED UNDERWRITING AGREEMENTUnderwriting Agreement • May 9th, 2017 • Cytokinetics Inc • Pharmaceutical preparations • New York
BETWEENExclusive License Agreement • January 27th, 2004 • Cytokinetics Inc • California
WARRANTWarrant Agreement • March 11th, 2004 • Cytokinetics Inc • Pharmaceutical preparations
CYTOKINETICS, INCORPORATED AND _____________, AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF __________ CYTOKINETICS, INCORPORATED FORM OF COMMON STOCK WARRANT AGREEMENTWarrant Agreement • November 18th, 2022 • Cytokinetics Inc • Pharmaceutical preparations • New York
THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
Exhibit 10.10 SECOND AMENDMENT TO LEASE THIS SECOND AMENDMENT TO LEASE ("Second Amendment"), dated (for reference purposes) as of July 11, 1999, is entered into by BRITANNIA POINTE GRAND LIMITED PARTNERSHIP, a Delaware limited partnership...Lease • January 27th, 2004 • Cytokinetics Inc
RECITALSCollaboration and License Agreement • April 29th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • New York
RECITALSLease Agreement • January 27th, 2004 • Cytokinetics Inc • California
7,106,600 Shares of Common Stock and Warrants to Purchase up to 3,553,300 Shares of Common Stock CYTOKINETICS, INCORPORATED PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • May 19th, 2009 • Cytokinetics Inc • Pharmaceutical preparations • New York
CYTOKINETICS, INCORPORATED and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of July 6, 2022 3.50% Convertible Senior Notes due 2027Indenture • July 6th, 2022 • Cytokinetics Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of July 6, 2022, between Cytokinetics, Incorporated, a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).
Exhibit 10.27 CYTOKINETICS, INCORPORATED AMENDMENT NO. 1 TO SERIES D PREFERRED STOCK PURCHASE AGREEMENT THIS AMENDMENT is made this 2nd day of April, 2003, between Cytokinetics, Incorporated, a Delaware corporation (the "Company"), Glaxo Wellcome...Series D Preferred Stock Purchase Agreement • January 27th, 2004 • Cytokinetics Inc • California
CYTOKINETICS, INCORPORATED Common Stock (par value $0.001 per share) At the Market Issuance Sales AgreementAt the Market Issuance Sales Agreement • June 13th, 2011 • Cytokinetics Inc • Pharmaceutical preparations • New York
Cytokinetics, Incorporated, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC (“MLV”), as follows:
RECITALSLoan and Security Agreement • March 11th, 2004 • Cytokinetics Inc • Pharmaceutical preparations
Exhibit 4.6 LOAN AND SECURITY AGREEMENT THIS AGREEMENT (the "Agreement"), dated as of December 16, 1999 (the "Closing Date") is entered into by and between Cytokinetics, Incorporated, a Delaware corporation having a principal place of business at 280...Loan and Security Agreement • March 11th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • Illinois
EXHIBIT 4.4 Amendment No. One to Loan and Security Agreement This Amendment Agreement No. One ("Amendment") to the Loan and Security Agreement dated as of September 25, 1998 is entered into this 1st day of February, 1999 by and between Cytokinetics,...Loan and Security Agreement • March 11th, 2004 • Cytokinetics Inc • Pharmaceutical preparations
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 15th, 2007 • Cytokinetics Inc • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 15, 2007, is by and between CYTOKINETICS, INCORPORATED (the “Company”) and KINGSBRIDGE CAPITAL LIMITED (the “Investor”).
CYTOKINETICS, INCORPORATED UNDERWRITING AGREEMENTUnderwriting Agreement • November 13th, 2019 • Cytokinetics Inc • Pharmaceutical preparations • New York
Exhibit 4.3 LOAN AND SECURITY AGREEMENT THIS AGREEMENT (the "Agreement"), dated as of September 25, 1998 (the "Closing Date") is entered into by and between Cytokinetics, Incorporated, a Delaware corporation having a principal place of business at 280...Loan and Security Agreement • March 11th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • Illinois
Cytokinetics, Incorporated 9,803,922 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • May 28th, 2024 • Cytokinetics Inc • Pharmaceutical preparations
Cytokinetics, Incorporated, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 9,803,922 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 1,470,588 additional shares (the “Optional Securities”) of common stock, par value $0.001 (“Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Securities”).
ContractWarrant Agreement • August 9th, 2019 • Cytokinetics Inc • Pharmaceutical preparations • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
ContractWarrant Agreement • March 3rd, 2016 • Cytokinetics Inc • Pharmaceutical preparations • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
